amifampridine has been researched along with Muscle Relaxation in 3 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Muscle Relaxation: That phase of a muscle twitch during which a muscle returns to a resting position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ionno, M | 1 |
| Moyer, M | 1 |
| Pollarine, J | 1 |
| van Lunteren, E | 1 |
| Fukushima, K | 1 |
| Aoki, T | 1 |
| Ishikawa, J | 1 |
| Uchida, Y | 1 |
3 other studies available for amifampridine and Muscle Relaxation
| Article | Year |
|---|---|
Inotropic effects of the K+ channel blocker 3,4-diaminopyridine on fatigued diaphragm muscle.
Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Animals; Diaphragm; Electric Stimulation; Electro | 2008 |
[Antagonistic effects of neostigmine, 4-aminopyridine and 3,4-diaminopyridine on muscle relaxing effects of d-tubocurarine].
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Muscle Contraction; Muscle Relaxation; Neos | 1983 |
Decreasing potassium conductance--a possible mechanism of phasic coronary vasospasm.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Calcium; Coronary Vasospasm; Coronary Vesse | 1985 |